Business Description
SK Bioscience is a South Korean company that develops, manufactures, and sells vaccines and biological medicines across domestic and international markets. Founded in 2018 and headquartered in Seongnam-si, it offers approved vaccines targeting influenza, shingles, pneumococcal disease, and chickenpox. The company also has a broad pipeline of candidates in various stages of clinical testing, including vaccines for rotavirus, cervical cancer, typhoid, COVID-19, and next-generation pneumococcal disease. SK Bioscience operates as a subsidiary of SK Chemicals Co., Ltd.